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ANKLE-BRACHIAL PRESSURE INDEX MEASURED
USING AN AUTOMATED OSCILLOMETRIC METHOD
AS A PREDICTOR OF THE SEVERITY OF
CORONARY ATHEROSCLEROSIS IN PATIENTS WITH
CORONARY ARTERY DISEASE
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Ankle-brachial pressure index (ABI) measured using a conventional Doppler method is an independent
predictor of the number of coronary vessels affected in coronary artery disease (CAD). Recently, a new
clinical device has been developed to measure ABI using an oscillometric method. It is unclear whether
ABI measured using this device is a significant predictor of the severity of coronary atherosclerosis. We
retrospectively included 87 patients from our outpatient clinic who had ever undergone coronary
angiography. ABI was determined in all subjects using the new ABI-form device. The lower value of ABI
in either limb was used for analysis. We divided our subjects into two groups, with either ABI less than
0.9 or at least 0.9, and compared basal characteristics between groups. We analyzed the relationship between
ABI and the severity of CAD. In addition, we calculated the sensitivity, specificity, and positive and negative
predictive values of ABI less than 0.9 in predicting multivessel (two-vessel + three-vessel) involvement
in our patients. There were 15 patients with ABI less than 0.9 and 72 with ABI at least 0.9. Patients with
ABI less than 0.9 were older and had higher plasma levels of uric acid. The prevalence of diabetes mellitus,
hypertension, smoking, and diuretic use was significantly higher in patients with ABI less than 0.9. In
addition, the group with ABI less than 0.9 had a lower prevalence of one-vessel CAD and higher prevalence
of three-vessel or multivessel CAD. The sensitivity, specificity, and positive and negative predictive values
of ABI less than 0.9 in predicting multivessel CAD were 22%, 96%, 93%, and 34%, respectively. In conclusion,
ABI measured using the automated oscillometric method can be used to predict the severity of coronary
atherosclerosis in patients with CAD.
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Ankle-brachial pressure index (ABI) is used in clinical
practice and epidemiologic studies as an indictor of peri-
pheral arterial occlusive disease (PAOD) [1–6]. Patients with
PAOD often have coronary atherosclerosis [7,8], and are
at increased risk for adverse cardiovascular events [1,9]. In
addition to traditional risk factors, ABI measured using a
conventional Doppler method is an independent predictor
of the number of coronary vessels affected [10]. Recently, a
new clinical device, ABI-form, has been developed to simul-
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taneously measure bilateral arm and ankle blood pres-
sures using an automated oscillometric method. The blood
pressures measured with the new device are highly
correlated with those obtained using the conventional
Doppler method (correlation coefficient 0.95) [11]. In this
study, we used the device to measure ABI in patients with
coronary artery disease (CAD) and analyzed whether the
ABI could serve as a significant predictor of the severity of
coronary atherosclerosis.
PATIENTS AND METHODS
We retrospectively included 87 patients (mean age, 64.9 ±
10.0 years) selected from our outpatient clinic. Demographic
data, history of diabetes mellitus, hypertension, smoking,
and antihypertensive drug use were recorded from chart
review. Total cholesterol, triglyceride, and uric acid levels
were checked before coronary angiography (CAG), which
was performed in all subjects. Angiographically significant
CAD was defined as at least 50% narrowing of a major cor-
onary artery. Before ABI measurement, height and weight
were measured and body mass index (BMI) was calculated.
ABI and systolic (SBP) and diastolic blood pressure (DBP)
were determined in all subjects using the ABI-form (VP-
1000; Nippon Colin, Komaki, Japan) device. This device has
four cuffs that can automatically and simultaneously
measure blood pressure using an oscillometric method in
both arms and ankles and calculate the ABI. The lower
value of ABI in either limb and left brachial SBP and DBP
were used for analysis.
We divided our subjects into two groups, with either
ABI < 0.9 or ≥ 0.9. Demographic data, CAD risk factors,
antihypertensive and antianginal drug use, plasma uric
acid level, and BMI were compared between the groups. We
analyzed the relationship between ABI and the severity of
CAD. In addition, we calculated the sensitivity, specificity,
and positive and negative predictive values of ABI < 0.9 in
predicting multivessel (two-vessel + three-vessel) involve-
ment in our patients.
Statistical analysis
All data were analyzed using SPSS version 11.0 (SPSS
Inc, Chicago, IL, USA). Results are presented as mean ±
standard deviation. Comparisons of continuous variables
between groups were made using the independent-samples
t test. Categorical variables were compared using the Chi-
squared or Fisher’s exact test. A p value of less than 0.05 was
considered statistically significant.
RESULTS
Baseline characteristics of patients are summarized in Table
1. There were 15 patients with ABI < 0.9 and 72 with ABI ≥
0.9. ABI values in the two groups were 0.77 ±  0.09 and
1.06 ±  0.08, respectively (p < 0.01). The 15 patients with
ABI < 0.9 were older and had higher plasma levels of uric
acid than those with ABI ≥ 0.9. The prevalence of diabetes
mellitus, hypertension, smoking, and diuretic use was
significantly greater in patients with ABI < 0.9.
The relationship between ABI and severity of CAD is
shown in Table 2. The prevalences of one-vessel, two-
vessel, and three-vessel CAD in patients with ABI ≥ 0.9
were 34.7% (25/72), 31.9% (23/72), and 33.3% (24/72),
respectively, and those with ABI < 0.9 were 6.7% (1/15),
26.7% (4/15), and 66.7% (10/15), respectively. The group
with ABI < 0.9 had a lower prevalence of one-vessel CAD
and a higher prevalence of three-vessel or multivessel
CAD. The sensitivity, specificity, and positive and negative
predictive values of ABI < 0.9 for multivessel CAD were
22%, 96%, 93%, and 34%, respectively.
DISCUSSION
ABI measured using a conventional Doppler method is a
useful indicator of PAOD, especially when it is less than 0.9.
In addition, ABI is a predictor of the extent of coronary
atherosclerosis and cardiovascular events in patients with
CAD [1–6,10]. A new device was recently developed to mea-
sure ABI using an automatic oscillometric method. The ma-
jor advantage of this device is that it can measure bilateral
arm and ankle blood pressures at the same time, and can cal-
culate the ABI using ankle and brachial SBP simultaneously.
Using this device, we measured the ABI in our patients, and
showed that smoking, hypertension, diabetes mellitus, and
age were significantly related to ABI. Smoking is one of the
major risk factors for the development of PAOD [1,3], and
can increase mortality in patients with symptomatic PAOD.
The significant association between diabetes mellitus and
ABI < 0.9 is in accordance with the clinical notion that dia-
betes mellitus is usually accompanied by more diffuse
atherosclerosis [12]. Drexler et al demonstrated that age,
smoking, and blood glucose were independent predictors
of the extent of PAOD [13]. In addition to these three varia-
bles, diuretic use, hypertension, and plasma levels of uric acid
were also significant predictors of PAOD in our study.
In this study, the prevalence of three-vessel or multivessel
CAD was significantly higher when ABI was less than 0.9;
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the prevalence of three-vessel CAD in patients with ABI <
0.9 (66.7%) was twice that in patients with ABI ≥ 0.9 (33.3%).
These findings are in agreement with the report that the
coexistence of PAOD in CAD patients is associated with
more diffuse and severe CAD [14].
The sensitivity, specificity, and positive and negative
predictive values of ABI < 0.9 for multivessel involvement
in our patients were 22%, 96%, 93%, and 34%, respectively.
The high specificity and high positive predictive value
were similar to those reported in previous studies [10,14].
These findings indicate that most patients with one-vessel
CAD have ABI ≥ 0.9, and also suggest that ABI measurement
is an effective method for predicting which patients with
CAD will have multivessel involvement.
Study limitations
This was a retrospective study and CAG was not simul-
taneously performed with ABI measurement. Thus, the
severity of CAD in some patients might have changed
before ABI data collection. We lacked follow-up data, so our
study could not provide any information about the progno-
sis of patients with CAD.
CONCLUSION
ABI measured using the automated oscillometric method
can be used to predict the severity of coronary atherosclerosis
in patients with CAD.
Table 1. Baseline characteristics of patients
Variable ABI ≥ 0.9 (n = 72) ABI < 0.9 (n = 15) p
ABI 1.06 ±  0.08 0.77 ±  0.09 < 0.01
Age (yr) 64.0 ±  10.2 69.0 ±  7.5 0.04
Gender (male) 58 11 0.50
BMI (kg/m2) 25.2 ±  3.1 24.2 ±  3.2 0.26
SBP (mmHg) 136.8 ±  19.4 145.0 ±  20.0 0.16
DBP (mmHg) 80.2 ±  10.6 78.8 ±  10.4 0.68
Total cholesterol (mg/dL) 198.5 ±  49.0 192.4 ±  69.6 0.76
Triglyceride (mg/dL) 159.7 ±  88.5 122.2 ±  115.9 0.28
Uric acid (mg/dL) 6.8 ±  1.8 8.7 ±  2.6 0.03
Use of β-blocker 47 10 0.92
Use of CCB 25 5 0.92
Use of ACEI 26 5 0.84
Use of ARB 28 8 0.30
Use of nitrate 51 11 1.00
Use of nicorandil 22 5 0.83
Use of diuretic 13 8 < 0.01
Hypertension 45 13 0.03
Diabetes mellitus 22 11 < 0.01
Smoking 26 10 0.03
ABI = ankle-brachial pressure index; BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; CCB = calcium
channel blocker; ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker.
Table 2. Relationship between ankle-brachial pressure index (ABI) and the severity of coronary artery disease
Variable ABI ≥ 0.9 (n = 72) ABI < 0.9 (n = 15) p
One-vessel disease 25 1 0.03
Two-vessel disease 23 4 0.77
Three-vessel disease 24 10 0.02
Multivessel disease 47 14 0.03
Multivessel = two-vessel + three-vessel.
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